Hantavirus Infections

Tropical Infectious Diseases

Volumn , Issue , 2011, Pages 470-480

  Fulhorst, Charles F ^a   Koster, Frederick T ^b   Enría, Delia A ^c   Peters, C J ^d  

^a University of Texas Medical Branch School of Medicine   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^c Instituto Nacional de Enfermedades Virales Humanas Dr Julio I Maiztegui   (Argentina)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84555164115     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-3935-5.00071-9     Document Type: Chapter

References (245)

1. Nichol ST, Beaty BJ, Elliott RM, et al. Family Bunyaviridae. Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses 2005, 695. Elsevier Academic Press, New York. C.M. Fauquet, M.A. Mayo, J. Maniloff (Eds.).
2. Carstens EB Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses. Arch Virol 2009, 155:133.
3. Goldsmith CS, Elliott LH, Peters CJ, Zaki SR Ultrastructural characteristics of Sin Nombre virus, causative agent of hantavirus pulmonary syndrome. Arch Virol 1995, 140:2107.
4. Schmaljohn C Bunyaviridae. Fields Virology 2007, 1742. Williams & Wilkins, Philadelphia: Lippincott. 5th ed. D.M. Knipe, P.M. Howley, D.E. Griffin (Eds.).
5. Henderson WW, Monroe MC, St Jeor SC, et al. Naturally occurring Sin Nombre virus genetic reassortment. Virology 1995, 214:602.
6. Plyusnin A, Kukkonen SK, Plyusnina A, et al. Transfection-mediated generation of functionally competent Tula hantavirus with recombinant S RNA segment. EMBO J 2002, 21:1497.
7. Razzauti M, Plyusnina A, Henttonen H, Plyusnin A Accumulation of point mutations and reassortment of genomic RNA segments are involved in the microevolution of Puumala hantavirus in a bank vole (Myodes glareolus) population. J Gen Virol 2008, 89:1649.
8. Kang W, Huang C, Bai X, Yang W, Li G A preliminary genetic reassortment between Hantaan virus and Seoul virus strains. Zhonghua Liu Xing Bing Xue Za Zhi 2002, 23:46.
9. Rodriguez LL, Owens JH, Peters CJ, Nichol ST Genetic reassortment among viruses causing hantavirus pulmonary syndrome. Virology 1998, 242:99.
10. Jääskeläinen KM, Kaukinen P, Minskaya ES, et al. Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter. J Med Virol 2007, 79:1527.
11. Spiropoulou CF, Morzunov S, Feldmann H, et al. Genome structure and variability of a virus causing hantavirus pulmonary syndrome. Virology 1994, 200:715.
12. Gavrilovskaya IN, Shepley M, Shaw R, et al. Beta(3) integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci USA 1998, 95:7074.
13. Gavrilovskaya IN, Brown EJ, Ginsberg MH, Mackow ER Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J Virol 1999, 73:3951.
14. Song J-W, Song K-J, Baek LJ, et al. In vivo characterization of the integrin beta(3) as a receptor for Hantaan virus cellular entry. Exp Mol Med 2005, 37:121.
15. Kang HJ, Bennett SN, Sumibcay L, et al. Evolutionary insights from a genetically divergent hantavirus harbored by the European common mole (Talpa europaea). PLoS ONE 2009, 4:e6149.
16. Ramsden C, Holmes EC, Charleston MA Hantavirus evolution in relation to its rodent and insectivore hosts: no evidence for codivergence. Mol Biol Evol 2009, 26:143.
17. Song JW, Baek LJ, Schmaljohn CS, Yanagihara R Thottapalayam virus, a prototype shrewborne hantavirus. Emerg Infect Dis 2007, 13:980.
18. LeDuc JW, Smith GA, Childs JE, et al. Global survey of antibody to Hantaan-related viruses among peridomestic rodents. Bull WHO 1986, 64:139.
19. Mills JN, Ksiazek TG, Ellis BA, et al. Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. Am J Trop Med Hyg 1997, 56:273.
20. Yates TL, Mills JN, Parmenter CA, et al. The ecology and evolutionary history of an emergent disease: hantavirus pulmonary syndrome. Bioscience 2002, 52:989.
21. Bayard V, Kitsutani PT, Barria EO, et al. Outbreak of hantavirus pulmonary syndrome, Los Santos, Panama, 1999-2000. Emerg Infect Dis 2004, 10:1635.
22. Carroll DS, Mills JN, Montgomery JM, et al. Hantavirus pulmonary syndrome in central Bolivia: relationships between reservoir hosts, habitats, and viral genotypes. Am J Trop Med Hyg 2005, 72:42.
23. Lyubsky S, Gavrilovskaya I, Luft B, Mackow E Histopathology of Peromyscus leucopus naturally infected with pathogenic NY-1 hantaviruses: pathologic markers of HPS viral infection in mice. Lab Invest 1996, 74:627.
24. Netski D, Thran BH, St Jeor SC Sin Nombre virus pathogenesis in Peromyscus maniculatus. J Virol 1999, 73:585.
25. Billings AN, Rollin PE, Milazzo ML, et al. Pathology of Black Creek Canal virus infection in juvenile hispid cotton rats (Sigmodon hispidus). Vector-Borne Zoonotic Dis 2010, 10. [Epub ahead of print].
26. Kallio ER, Voutilainen L, Vapalahti O, et al. Endemic hantavirus infection impairs the winter survival of its rodent host. Ecology 2007, 88:1911.
27. Calisher CH, Root JJ, Mills JN, et al. Epizootiology of Sin Nombre and El Moro Canyon hantaviruses, southeastern Colorado, 1995-2000. J Wildl Dis 2005, 41:1.
28. Nowotny N The domestic cat: a possible transmitter of viruses from rodents to man. Lancet 1994, 343:921.
29. Kawamata J, Yamanouchi T, Dohmae K, et al. Control of laboratory acquired hemorrhagic fever with renal syndrome (HFRS) in Japan. Lab Anim Sci 1987, 37:431.
30. Tsai TF Hemorrhagic fever with renal syndrome: mode of transmission to humans. Lab Anim Sci 1987, 37:428.
31. Laboratory management of agents associated with hantavirus pulmonary syndrome: interim biosafety guidelines. MMWR Morb Mortal Wkly Rep 1994, 3:1. Anonymous.
32. Dournon E, Moriniere B, Matheron S, et al. HFRS after a wild rodent bite in the haute-Savoie and a risk of exposure to Hantaan-like virus in a Paris laboratory. Lancet 1984, 1:676.
33. Lee HW, Baek LJ, Johnson KM Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats. J Infect Dis 1982, 146:638.
34. Torres-Pérez F, Wilson L, Collinge SK, et al. Sin Nombre virus infection in field workers, Colorado, USA. Emerg Infect Dis 2010, 16:308.
35. Wong T-W, Chan Y-C, Yap E-H, et al. Serological evidence of hantavirus infection in laboratory rats and personnel. Int J Epidemiol 1988, 17:887.
36. Padula PJ, Edelstein A, Miguel SDL, et al. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 1998, 241:323.
37. Gauld RL, Craig JP Epidemiological pattern of localized outbreaks of epidemic hemorrhagic fever. Am J Hyg 1954, 59:32.
38. Lázaro ME, Cantoni GE, Calanni LM, et al. Clusters of hantavirus infection, southern Argentina. Emerg Infect Dis 2007, 13:104.
39. Wells RM, Estani SS, Yadon ZE, et al. An unusual hantavirus outbreak in southern Argentina: person-to-person transmission?. Emerg Infect Dis 1997, 3:171.
40. Wells RM, Young J, Williams RJ, et al. Hantavirus transmission in the United States. Emerg Infect Dis 1997, 3:361.
41. Nuzum EO, Rossi CA, Stephenson EH, LeDuc JW Aerosol transmission of Hantaan and related viruses to laboratory rats. Am J Trop Med Hyg 1988, 38:636.
42. Godoy P, Marsac D, Stefas E, et al. Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome. J Virol 2009, 83:5046.
43. Hutchinson KL, Rollin PE, Peters CJ Pathogenesis of a North American hantavirus, Black Creek Canal virus, in experimentally infected Sigmodon hispidus. Am J Trop Med Hyg 1998, 59:58.
44. Lee H-W, Lee P-W, Baek LJ, et al. Intraspecific transmission of Hantaan virus, etiologic agent of Korean hemorrhagic fever, in the rodent Apodemus agrarius. Am J Trop Med Hyg 1981, 30:1106.
45. Yanagihara R, Amyx HL, Gajdusek DC Experimental infection with Puumala virus, the etiologic agent of nephropathia epidemica, in bank voles (Clethrionomys glareolus). J Virol 1985, 55:34.
46. Armstrong LR, Zaki SR, Goldoft MJ, et al. Hantavirus pulmonary syndrome associated with entering or cleaning rarely used, rodent-infested structures. J Infect Dis 1995, 172:1166.
47. Crowcroft NS, Infuso A, Ilef D, et al. Risk factors for human hantavirus infection: Franco-Belgian collaborative case-control study during 1995-1996 epidemic. Br Med J 1999, 318:1737.
48. Hantavirus pulmonary syndrome - United States: update recommendations for risk reduction. MMWR Recomm Rep 2002, 51:1. Anonymous.
49. Van Loock F, Thomas I, Clement J, et al. A case-control study after a hantavirus infection outbreak in the south of Belgium: who is at risk?. Clin Infect Dis 1999, 28:834.
50. Korpela H, Lähdevirta J The role of small rodents and patterns of living in the epidemiology of nephropathia epidemica. Scand J Infect Dis 1978, 10:303.
51. Dixon KE, Nang RN, Kim D-H, et al. A hospital-based, case-control study of risk factors for hemorrhagic fever with renal syndrome in soldiers of the armed forces of the Republic of Korea. Am J Trop Med Hyg 1996, 54:284.
52. Lokugamage K, Kariwa H, Hayasaka D, et al. Genetic characterization of hantaviruses transmitted by the Korean field mouse (Apodemus peninsulae), Far East Russia. Emerg Infect Dis 2002, 8:768.
53. Park S-C, Pyo H-J, Soe J-B, et al. A clinical study of hemorrhagic fever with renal syndrome caused by Seoul virus infection. Korean J Intern Med 1989, 4:130.
54. Chen H-X, Qiu F-X, Dong B-J, et al. Epidemiological studies on hemorrhagic fever with renal syndrome in China. J Infect Dis 1986, 154:394.
55. Li Y-L, Ruo SL, Tong Z, et al. A serotypic study of hemorrhagic fever with renal syndrome in rural China. Am J Trop Med Hyg 1995, 52:247.
56. LeDuc JW Epidemiology of Hantaan and related viruses. Lab Anim Sci 1987, 37:413.
57. Lloyd G, Jones N Infection of laboratory workers with hantavirus acquired from immunocytomas propagated in laboratory rats. J Infect 1986, 12:117.
58. Woods C, Palekar R, Kim P, et al. Domestically acquired Seoul virus causing hemorrhagic fever with renal syndrome-Maryland, 2008. Clin Infect Dis 2009, 49:e109.
59. Antoniadis A, Stylianakis A, Papa A, et al. Direct genetic detection of Dobrava virus in Greek and Albanian patients with hemorrhagic fever with renal syndrome. J Infect Dis 1996, 174:407.
60. Avsic-Zupanc T, Poljak M, Furlan P, et al. Isolation of a strain of Hantaan virus from a fatal case of hemorrhagic fever with renal syndrome in Slovenia. Am J Trop Med Hyg 1994, 51:393.
61. Taller AM, Xiao SY, Godec MS, et al. Belgrade virus, a cause of hemorrhagic fever with renal syndrome in the Balkans, is closely related to Dobrava virus of field mice. J Infect Dis 1993, 168:750.
62. Lähdevirta J Nephropathia epidemica in Finland. A clinical histological and epidemiological study. Ann Clin Res 1971, 3:1.
63. Mustonen J, Brummer-Korvenkontio M, Hedman K, et al. Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis 1994, 26:7.
64. Niklasson B, Hornfeldt B, Mullaart M, et al. An epidemiologic study of hemorrhagic fever with renal syndrome in Bashkirtostan (Russia) and Sweden. Am J Trop Med Hyg 1993, 48:670.
65. Rollin PE, Coudrier D, Sureau P Hantavirus epidemic in Europe, 1993. Lancet 1994, 343:115.
66. Golovljova I, Vasilenko V, Mittzenkov V, et al. Characterization of hemorrhagic fever with renal syndrome caused by hantaviruses, Estonia. Emerg Infect Dis 2007, 13:1773.
67. Clement J, McKenna P, van der Groen G, et al. Hantaviruses. Zoonoses, Biology, Clinical Practice and Public Health Control 1998, 331. Oxford University Press, Oxford. S.R. Palmer, E.J.L. Soulsby, D.I.H. Simpson (Eds.).
68. Lee HW, Lee PW, Baek LJ, Chu YK Geographical distribution of hemorrhagic fever with renal syndrome and hantaviruses. Arch Virol 1990, 1(s):5.
69. Chandy S, Boorugu H, Chrispal A, et al. Hantavirus infection: a case report from India. Indian J Med Microbiol 2009, 27:267.
70. Chandy S, Yoshimatsu K, Boorugu HK, et al. Acute febrile illness caused by hantavirus: Serological and molecular evidence from India. Trans R Soc Trop Med Hyg 2009, 103:407.
71. Klempa B, Fichet-Calvet E, Lecompte E, et al. Hantavirus in African wood mouse, Guinea. Emerg Infect Dis 2006, 12:838.
72. Klempa B, Koivogui L, Sylla O, et al. Serological evidence of human hantavirus infections in Guinea, West Africa. J Infect Dis 2010, 201:1031.
73. Chu YK, Owen RD, Sanchez-Hernandez C, et al. Genetic characterization and phylogeny of a hantavirus from western Mexico. Virus Res 2008, 131:180.
74. Milazzo ML, Cajimat MNB, Hanson JD, et al. Catacamas virus, a hantaviral species naturally associated with Oryzomys couesi (Coues' oryzomys) in Honduras. Am J Trop Med Hyg 2006, 75:1003.
75. Hjelle B, Anderson B, Torrez-Martinez N, et al. Prevalence and geographic genetic variation of hantaviruses of the New World harvest mice (Reithrodontomys) - identification of a divergent genotype from a Costa Rican Reithrodontomys mexicanus. Virology 1995, 207:452.
76. Fulhorst CF, Monroe MC, Salas RA, et al. Isolation, characterization and geographic distribution of Caño Delgadito virus, a newly discovered South American hantavirus (family Bunyaviridae). Virus Res 1997, 5:159.
77. Fulhorst CF, Cajimat MNB, Utrera A, et al. Maporal virus, a hantavirus associated with the fulvous pygmy rice rat (Oligoryzomys fulvescens) in western Venezuela. Virus Res 2004, 104:139.
78. Powers AM, Mercer DR, Watts DM, et al. Isolation and genetic characterization of a hantavirus (Bunyaviridae: Hantavirus) from a rodent, Oligoryzomys microtis (Muridae), collected in northeastern Peru. Am J Trop Med Hyg 1999, 61:92.
79. Schmaljohn C Vaccines for hantaviruses. Vaccine 2009, 27(suppl 4):D61.
80. Zeitz PS, Butler JC, Cheek JE, et al. A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. J Infect Dis 1995, 171:864.
81. Simonsen L, Dalton MJ, Breiman RF, et al. Evaluation of the magnitude of the 1993 hantavirus outbreak in the southwestern United States. J Infect Dis 1995, 172:729.
82. Zavasky D-M, Hjelle B, Peterson MC, et al. Acute infection with Sin Nombre hantavirus without pulmonary edema. Clin Infect Dis 1999, 29:664.
83. Gonzalez LM, Lindsey AE, Hjelle B, et al. Prevalence of antibodies to Sin Nombre virus in humans living in rural areas of southern New Mexico and western Texas. Virus Res 2001, 74:177.
84. Zeitz PS, Graber JM, Voorhees RA, et al. Assessment of occupational risk for hantavirus infection in Arizona and New Mexico. J Occup Environ Med 1997, 39:463.
85. Fulhorst CF, Milazzo ML, Armstrong LR, et al. Hantavirus and arenavirus antibodies in persons with occupational rodent exposure, North America. Emerg Infect Dis 2007, 13:532.
86. Castillo C, Villagra E, Sanhueza L, et al. Prevalence of antibodies to hantavirus among family and health care workers contacts of persons with hantavirus cardiopulmonary syndrome: lack of evidence for nosocomial transmission of Andes virus to health care workers in Chile. Am J Trop Med Hyg 2004, 70:302.
87. Vincent MJ, Quiroz E, Gracia F, et al. Hantavirus pulmonary syndrome in Panama: Identification of novel hantaviruses and their likely reservoirs. Virology 2000, 277:14.
88. Nelson R, Cañate R, Pascale JM, et al. Confirmation of Choclo virus as the cause of hantavirus cardiopulmonary syndrome and high serum antibody prevalence in Panama. J Med Virol 2010, 82:1586.
89. Armien B, Pascale JM, Bayard V, et al. High seroprevalence of hantavirus infection on the Azuero Peninsula of Panama. Am J Trop Med Hyg 2004, 70:682.
90. Enria DA, Briggiler AM, Pini N, Levis S Clinical manifestations of New World hantaviruses. Curr Top Microbiol Immunol 2001, 256:117.
91. Koster FT, Levy H Hantavirus cardiopulmonary syndrome: a new twist to an established pathogen. New and Evolving Infections of the 21st Century 2006, 151. Springer-Verlag, New York. I.W. Fong, K. Alibek (Eds.).
92. Vapalahti O, Lundkvist A, Vaheri A Human immune response, host genetics, and severity of disease. Curr Top Microbiol Immunol 2001, 256:153.
93. Hemorrhagic fever with renal syndrome: memorandum from a WHO meeting. Bull WHO 1983, 61:296. Anonymous.
94. Giles RB, Sheedy JA, Ekman CN, et al. The sequelae of epidemic hemorrhagic fever, with a note on causes of death. Am J Med 1954, 16:629.
95. Powell GM Hemorrhagic fever: a study of 300 cases. Medicine (Baltimore) 1954, 33:97.
96. Lee H-W Hemorrhagic fever with renal syndrome in Korea. Rev Infect Dis 1989, 11:864.
97. Lee J-S, Cho B-Y, Lee M-C, et al. Clinical features of serologically proven Korean hemorrhagic fever patients. Seoul J Med 1980, 21:163.
98. Lee M, Kim B-K, Kim S, et al. Coagulopathy in hemorrhagic fever with renal syndrome (Korean hemorrhagic fever). Rev Infect Dis 1989, 11:S877.
99. Entwisle GM, Hale EH Hemodynamic alterations in hemorrhagic fever. Circulation 1957, 15:414.
100. Koh C, Kim W, Lee JS, et al. Clinical study of Korean hemorrhagic fever. Korean J Med 1972, 15:757.
101. Smyth AG, Powell GM The electrocardiogram in hemorrhagic fever. Am Heart J 1954, 47:218.
102. Kim Y-S, Lee J-S, Ahn C, et al. Magnetic resonance imaging of the kidney in hemorrhagic fever with renal syndrome: its histopathologic correlation. Nephron 1997, 76:477.
103. Valiakhmetov RZ, Gafarov AI, Memkhes VS, Galimzianov VZ Spontaneous rupture of the kidneys in hemorrhagic fever with renal syndrome. Urol Nefrol (Mosk) 1990, 6:50.
104. Lee HG, Han JS, Kim S, Chang KH Panhypopituitarism in the acute stage of hemorrhagic fever renal syndrome: a case report. Arch Virol Suppl 1990, 1:95.
105. Kim Y-S, Ahn C, Han J-S, Kim S, et al. Hemorrhagic fever with renal syndrome caused by the Seoul virus. Nephron 1995, 71:419.
106. Lee HW, van der Groen G Hemorrhagic fever with renal syndrome. Prog Med Virol 1989, 36:62.
107. Glass GE, Watson AJ, LeDuc JW, et al. Infection with a ratborne hantavirus in US residents is consistently associated with hypertensive renal disease. J Infect Dis 1993, 167:614.
108. Settergren B, Juto P, Trollfors B, et al. Clinical characteristics of nephropathia epidemica in Sweden: prospective study of 74 cases. Rev Infect Dis 1989, 11:921.
109. Colson P, Damoiseaux P, Brisbois J, et al. Epidemie d'hantavirose dans l'Entre-Sambre-et-Meuse, années 1992-1993. Données cliniques et biologiques. Acta Clin Belg 1995, 50:197.
110. Kontkanen M, Puustjärvi T, Lähdevirta J Myopic shift and its mechanism in nephropathia epidemica or Puumala virus infection. Br J Ophthalmol 1994, 78:903.
111. Kontkanen MI, Puustjarvi TJ, Lähdevirta JK Intraocular pressure changes in nephropathia epidemica - a prospective study of 37 patients with acute systemic Puumala virus infection. Ophthalmology 1995, 102:1813.
112. Linderholm M, Settergren B, Ahlm C, et al. A Swedish fatal case of nephropathia epidemica. Scand J Infect Dis 1991, 23:501.
113. Valtonen M, Kauppila M, Kotilainen P, et al. Four fatal cases of nephropathia epidemica. Scand J Infect Dis 1995, 27:515.
114. Kleinknecht D, Rollin PE Hypertension after hemorrhagic fever with renal syndrome. Nephron 1992, 61:121.
115. Niklasson B, Hellsten G, LeDuc J Hemorrhagic fever with renal syndrome: A study of sequelae following nephropathia epidemica. Arch Virol 1994, 137:241.
116. Alexeyev OA, Baranov BA Puumala virus infection without signs of renal involvment. Scand J Infect Dis 1993, 25:525.
117. Niklasson B, LeDuc JW, Nyström K, Nyman L Nephropathia epidemica: Incidence of clinical cases and antibody prevalence in an endemic area of Sweden. Epidemiol Infect 1987, 99:559.
118. Vapalahti O, Mustonen J, Lundkvist A, et al. Hantavirus infections in Europe. Lancet Infect Dis 2003, 3:653.
119. Avsic-Zupanc T, Petrovec M, Furlan P, et al. Hemorrhagic fever with renal syndrome in the Dolenjska region of Slovenia - a 10-year survey. Clin Infect Dis 1999, 28:860.
120. Kruger DH, Ulrich R, Lundkvist AA Hantavirus infections and their prevention. Microbes Infect 2001, 3:1129.
121. Pekic S, Cvijovic G, Stojanovic M, et al. Hypopituitarism as a late complication of hemorrhagic fever. Endocrine 2005, 26:79.
122. Stojanovic M, Pekic S, Cvijovic G, et al. High risk of hypopituitarism in patients who recovered from hemorrhagic fever with renal syndrome. J Clin Endocrinol Metab 2008, 93:2722.
123. Nichol ST, Spiropoulou CF, Morzunov S, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993, 262:914.
124. Kitsutani PT, Denton RW, Fritz CL, et al. Acute Sin Nombre hantavirus infection without pulmonary syndrome, United States. Emerg Infect Dis 1999, 5:701.
125. Castillo C, Naranjo J, Sepulveda A, et al. Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile: clinical experience with 16 adults. Chest 2001, 120:548.
126. Riquelme R, Riquelme M, Torres A, et al. Hantavirus pulmonary syndrome, southern Chile. Emerg Infect Dis 2003, 9:1438.
127. Vial PA, Valdivieso F, Mertz G, et al. Incubation period of hantavirus cardiopulmonary syndrome. Emerg Infect Dis 2006, 12:1271.
128. Duchin JS, Koster F, Peters CJ, et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med 1994, 330:949.
129. Ketai LH, Williamson MR, Telepak RJ, et al. Hantavirus pulmonary syndrome - radiographic findings in 16 patients. Radiology 1994, 191:665.
130. Hallin GW, Simpson SQ, Crowell RE, et al. Cardiopulmonary manifestations of hantavirus pulmonary symptoms. Crit Care Med 1996, 24:252.
131. Moolenaar RL, Dalton C, Lipman HB, et al. Clinical features that differentiate hantavirus pulmonary syndrome from three other acute respiratory illnesses. Clin Infect Dis 1995, 21:643.
132. Khan AS, Ksiazek TG, Peters CJ Hantavirus pulmonary syndrome. Lancet 1996, 347:739.
133. Hallin GW, Simpson SQ, Crowell RE, et al. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med 1996, 24:252.
134. Koster F, Foucar K, Hjelle B, et al. Rapid presumptive diagnosis of hantavirus cardiopulmonary syndrome by peripheral blood smear review. Am J Clin Pathol 2001, 116:665.
135. Nolte KB, Feddersen RM, Foucar K, et al. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Human Pathol 1995, 26:110.
136. Zaki S, Greer PW, Coffield LM, et al. Hantavirus pulmonary syndrome: Pathogenesis of an emerging infectious disease. Am J Pathol 1995, 146:552.
137. Levy H Hantavirus infection. Curr Opin Infect Dis 1997, 10:103.
138. Chang B, Crowley M, Campen M, Koster F Hantavirus cardiopulmonary syndrome. Semin Respir Crit Care Med 2007, 28:193.
139. Pergam SA, Schmidt DW, Nofchissey RA, et al. Potential renal sequelae in survivors of hantavirus cardiopulmonary syndrome. Am J Trop Med Hyg 2009, 80:279.
140. Levis S, Morzunov SP, Rowe JE, et al. Genetic diversity and epidemiology of hantaviruses in Argentina. J Infect Dis 1998, 177:529.
141. Lopez N, Padula P, Rossi C, et al. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 1996, 220:223.
142. Parisi M, Enria E, Padula P, et al. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Medicina (B Aires) 1996, 56:1.
143. Hantavirus pulmonary syndrome - Chile, 1997. MMWR Morb Mortal Wkly Rep 1997, 46:949. Anonymous.
144. Iversson LB, da Rosa AP, Rosa MD, et al. [Human infection by hantavirus in southern and southeastern Brazil. Rev Assoc Med Bras 1994, 40:85.
145. Williams RJ, Bryan RT, Mills JN, et al. An outbreak of hantavirus pulmonary syndrome in western Paraguay. Am J Trop Med Hyg 1997, 57:274.
146. Khan AS, Gaviria M, Rollin PE, et al. Hantavirus pulmonary syndrome in Florida: association with the newly identified Black Creek Canal virus. Am J Med 1996, 100:46.
147. Khan AS, Spiropoulou CF, Morzunov S, et al. Fatal illness associated with a new hantavirus in Louisiana. J Med Virol 1995, 46:281.
148. Hjelle B, Goade D, Torrez-Martinez N, et al. Hantavirus pulmonary syndrome, renal insufficiency, and myositis associated with infection by Bayou hantavirus. Clin Infect Dis 1996, 23:495.
149. Zaki SR, Peters CJ Viral hemorrhagic fevers. The Pathology of Infectious Diseases 1997, 347. Appleton and Lange, Stamford, CT. D.H. Connor, F.W. Chandler, D.A. Schwartz (Eds.).
150. Smadel JE Epidemic hemorrhagic fever. Am J Public Health Nations Health 1953, 43:1327.
151. Smorodinstev AA, Chudokov VG, et al. Hemorrhagic Nephrosonephritis. Hemorrhagic Nephrosonephritis 1959, Pergamon Press, New York. A.A. Smorodinstev, V.G. Chudokov, A.V. Churliov (Eds.).
152. Forslund T, Saltevo J, Anttinen J, et al. Complications of nephropathia epidemica: three cases. J Intern Med 1992, 232:87.
153. Hullinghorst RL, Steer A Pathology of epidemic hemorrhagic fever. Ann Intern Med 1953, 38:77.
154. Lukes RJ The pathology of thirty-nine fatal cases of epidemic hemorrhagic fever. Am J Med 1954, 16:639.
155. Zaki SR Hantavirus-associated diseases. The Pathology of Infectious Diseases 1997, 125. Appleton and Lange, Stamford, CT. D.H. Connor, F.W. Chandler, D.A. Schwartz (Eds.).
156. Nolte KB, Feddersen RM, Foucar K, et al. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol 1995, 26:110.
157. Mori M, Rothman AL, Kurane I, et al. High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis 1999, 179:295.
158. Mackow ER, Gavrilovskaya IN Hantavirus regulation of endothelial cell functions. Thromb Haemost 2009, 102:1030.
159. Sundstrom JB, McMullan LK, Spiropoulou CF, et al. Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J Virol 2001, 75:6070.
160. Hayasaka D, Maeda K, Ennis FA, Terajima M Increased permeability of human endothelial cell line EA.hy926 induced by hantavirus-specific cytotoxic T lymphocytes. Virus Res 2007, 123:120.
161. Gavrilovskaya IN, Gorbunova EE, Mackow NA, Mackow ER Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J Virol 2008, 82:5797.
162. Khaiboullina SF, Netski DM, Krumpe P, St Jeor SC Effects of tumor necrosis factor alpha on Sin Nombre virus infection in vitro. J Virol 2000, 74:11966.
163. Davis IC, Zajac AJ, Nolte KB, et al. Elevated generation of reactive oxygen/nitrogen species in hantavirus cardiopulmonary syndrome. J Virol 2002, 76:8347.
164. Peters CJ Pathogenesis of viral hemorrhagic fevers. Viral Pathogenesis 1997, 779. Lippincott-Raven, Philadelphia. N. Nathanson, R. Ahmed, F. Gonzalez-Scarano (Eds.).
165. Sirotin BZ, Obukhova GG, Mogila TV [Kallikrein-kinin, coagulative and fibrinolytic blood systems in patients with hemorrhagic fever and renal syndrome. Ter Arkh 1981, 53:84.
166. Krakauer T, LeDuc JW, Morrill JC, et al. Serum levels of alpha and gamma interferons in hemorrhagic fever with renal syndrome. Viral Immunol 1994, 7:97.
167. Linderholm M, Ahlm C, Settergren B, et al. Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis 1996, 173:38.
168. Groeneveld PH, Colson P, Kwappenberg KMC, Clement J Increased production of nitric oxide (NO) in patients infected with the European variant of hantavirus. Scand J Infect Dis 1995, 27:453.
169. Gavrilovskaya IN, Podgorodnichenko VK, Apekina NS, et al. Determination of specific immune complexes and dynamics of their circulation in patients suffering from hemorrhagic fever with a renal syndrome. Mikrobiol Zhurn 1987, 49:71.
170. Jokinen EJ, Lähdevirta J, Collan Y Nephropathia epidemica: immunohistochemical study of pathogenesis. Clin Nephrol 1978, 9:1.
171. Penttinen K, Lähdevirta J, Kekomäki R, et al. Circulating immune complexes, immunoconglutinins, and rheumatoid factors in nephropathia epidemica. J Infect Dis 1981, 143:15.
172. Plyusnin A, Horling J, Kanerva M, et al. Puumala hantavirus genome in patients with nephropathia epidemica: correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents. J Clin Microbiol 1997, 35:1090.
173. Sheedy JA, Froeb HF, Batson HA, et al. The clinical course of epidemic hemorrhagic fever. Am J Med 1954, 16:619.
174. Temonen M, Vapalahti O, Holthofer H, et al. Susceptibility of human cells to Puumala virus infection. J Gen Virol 1993, 74:515.
175. Kim S, Kang E-T, Kim Y-G, et al. Localization of Hantaan viral envelope glycoproteins by monoclonal antibodies in renal tissues from patients with Korean hemorrhagic fever. Am J Clin Pathol 1993, 100:398.
176. Mackow ER, Gavrilovskaya IN Hantavirus regulation of endothelial cell functions. Thromb Haemost 2009, 102:1030.
177. Koster FT, Simpson SQ, Feddersen KM, et al. Immunopathogenesis of hantavirus pulmonary syndrome (HPS): role of the T cell. In US-Japan Cooperative Medical Sciences Program. Abstracts of the 29th Joint Viral Diseases Panels Meeting, Santa Fe, New Mexico, 1996.
178. Ennis FA, Cruz J, Spiropoulou CF, et al. Hantavirus pulmonary syndrome: CD8(+) and CD4(+) cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness. Virology 1997, 238:380.
179. + T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J Immunol 2004, 172:3297.
180. Terajima M, Hendershot JD, Kariwa H, et al. High levels of viremia in patients with the hantavirus pulmonary syndrome. J Infect Dis 1999, 180:2030.
181. Xiao R, Yang S, Koster F, et al. Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. J Infect Dis 2006, 194:1403.
182. Bharadwaj M, Nofchissey R, Goade D, et al. Humoral immune responses in the hantavirus cardiopulmonary syndrome. J Infect Dis 2000, 182:43.
183. Saggioro FP, Rossi MA, Duarte MI, et al. Hantavirus infection induces a typical myocarditis that may be responsible for myocardial depression and shock in hantavirus pulmonary syndrome. J Infect Dis 2007, 195:1541.
184. Linderholm M, Billstrom A, Settergren B, Tarnvik A Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography. Infection 1992, 20:263.
185. Linderholm M, Sandstrom T, Rinnstrom O, et al. Impaired pulmonary function in patients with hemorrhagic fever with renal syndrome. Clin Infect Dis 1997, 25:1084.
186. Kim D-S Clinical analysis of 111 fatal cases of epidemic hemorrhagic fever. Am J Med 1965, 39:218.
187. Bruno P, Hassell LH, Brown J, et al. The protean manifestations of hemorrhagic fever with renal syndrome. A retrospective review of 26 cases from Korea. Ann Intern Med 1990, 113:385.
188. Clement J, Colson P, McKenna P Hantavirus pulmonary syndrome in New England and Europe. N Engl J Med 1994, 331:545.
189. McElroy AK, Bray M, Reed DS, Schmaljohn CS Andes virus infection of cynomolgus macaques. J Infect Dis 2002, 186:1706.
190. Hooper JW, Larsen T, Custer DM, Schmaljohn CS A lethal disease model for hantavirus pulmonary syndrome. Virology 2001, 289:6.
191. Milazzo ML, Eyzaguirre EJ, Molina CP, Fulhorst CF Maporal viral infection in the Syrian golden hamster: a model of hantavirus pulmonary syndrome. J Infect Dis 2002, 186:1390.
192. Campen MJ, Milazzo ML, Fulhorst CF, et al. Characterization of shock in a hamster model of hantavirus infection. Virology 2006, 356:45.
193. Wahl-Jensen V, Chapman J, Asher L, et al. Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters. J Virol 2007, 81:7449.
194. Custer DM, Thompson E, Schmaljohn CS, et al. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. J Virol 2003, 77:9894.
195. Hooper JW, Ferro AM, Wahl-Jensen V Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus. J Virol 2008, 82:1332.
196. Safronetz D, Hegde NR, Ebihara H, et al. Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with Andes virus. J Virol 2009, 83:7285.
197. Eyzaguirre EJ, Milazzo ML, Koster FT, Fulhorst CF Choclo virus infection in the Syrian golden hamster. Am J Trop Med Hyg 2008, 78:669.
198. Hooper JW, Custer DM, Thompson E, et al. DNA vaccination with the Hantaan virus M gene protects hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in rhesus monkeys. J Virol 2001, 75:8469.
199. Niklasson B, Kjelsson T Detection of nephropathia epidemica (Puumala virus)-specific immunoglobulin M by enzyme-linked immunosorbent assay. J Clin Microbiol 1988, 26:1519.
200. Clement J, McKenna P, Groen J, et al. Epidemiology and laboratory diagnosis of hantavirus (HTV) infections. Acta Clin Belg 1995, 50:9.
201. Jenison S, Yamada T, Morris C, et al. Characterization of human antibody responses to Four Corners hantavirus infections among patients with hantavirus pulmonary syndrome. J Virol 1994, 68:3000.
202. Ksiazek TG, Peters CJ, Rollin PE, et al. Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg 1995, 52:1017.
203. Duermeyer W, Wieland F, van der Veen J A new principle for the detection of specific IgM antibodies applied in an ELISA for hepatitis A. J Med Virol 1979, 4:25.
204. Elgh F, Wadell G, Juto P Comparison of the kinetics of Puumala virus specific IgM and IgG antibody responses in nephropathia epidemica as measured by a recombinant antigen-based enzyme-linked immunosorbent assay and an immunofluorescence test. J Med Virol 1995, 45:146.
205. Bostik P, Winter J, Ksiazek TG, et al. Sin Nombre virus (SNV) Ig isotype antibody response during acute and convalescent phases of hantavirus pulmonary syndrome. Emerg Infect Dis 2000, 6:184.
206. Feldmann H, Sanchez A, Morzunov S, et al. Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res 1993, 30:351.
207. Groen J, Dalrymple J, Fisher-Hoch S, et al. Serum antibodies to structural proteins of hantavirus arise at different times after infection. J Med Virol 1992, 37:283.
208. Hjelle B, Chavez-Giles F, Torrez-Martinez N, et al. Dominant glycoprotein epitope of Four Corners hantavirus is conserved across a wide geographical area. J Gen Virol 1994, 75:2881.
209. Lundkvist A, Björsten S, Niklasson B Immunoglobulin G subclass responses against the structural components of Puumala virus. J Clin Microbiol 1993, 31:368.
210. Vapalahti O, Lundkvist A, Fedorov V, et al. Isolation and characterization of a hantavirus from Lemmus sibiricus: evidence for host switch during hantavirus evolution. J Virol 1999, 73:5586.
211. Niklasson B, Jonsson M, Lundkvist A, et al. Comparison of European isolates of viruses causing hemorrhagic fever with renal syndrome by a neutralization test. Am J Trop Med Hyg 1991, 45:660.
212. Elgh F, Linderholm M, Wadell G, et al. Development of humoral cross-reactivity to the nucleocapsid protein of heterologous hantaviruses in nephropathia epidemica. FEMS Immunol Med Microbiol 1998, 22:309.
213. Hujakka H, Koistinen V, Kuronen I, et al. Diagnostic rapid tests for acute hantavirus infections: specific tests for Hantaan, Dobrava and Puumala viruses versus a hantavirus combination test. J Virol Methods 2003, 108:117.
214. Brus Sjolander K, Lundkvist A Dobrava virus infection: serological diagnosis and cross-reactions to other hantaviruses. J Virol Methods 1999, 80:137.
215. Lundkvist A, Hukic M, Horling J, et al. Puumala and Dobrava viruses cause hemorrhagic fever with renal syndrome in Bosnia-Herzegovina: evidence of highly cross-neutralizing antibody responses in early patient sera. J Med Virol 1997, 53:51.
216. Ye C, Prescott J, Nofchissey R, et al. Neutralizing antibodies and Sin Nombre virus RNA after recovery from hantavirus cardiopulmonary syndrome. Emerg infect Dis 2004, 10:478.
217. Galeno H, Mora J, Villagra E, et al. First human isolate of hantavirus (Andes virus) in the Americas. Emerg Infect Dis 2002, 8:657.
218. Hjelle B, Spiropoulou CF, Torrez-Martinez N, et al. Detection of Muerto Canyon virus RNA in peripheral blood mononuclear cells from patients with hantavirus pulmonary syndrome. J Infect Dis 1994, 170:1013.
219. Aitichou M, Saleh SS, McElroy AK, et al. Identification of Dobrava, Hantaan, Seoul, and Puumala viruses by one-step real-time RT-PCR. J Virol Methods 2005, 124:21.
220. Evander M, Eriksson I, Pettersson L, et al. Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J Clin Microbiol 2007, 45:2491.
221. Saksida A, Duh D, Korva M, Avsic-Zupanc T Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome. J Infect Dis 2008, 197:681.
222. Schwarz TF, Zaki SR, Morzunov S, et al. Detection and sequence confirmation of Sin Nombre virus RNA in paraffin-embedded human tissues using one-step RT-PCR. J Virol Methods 1995, 51:349.
223. Zaki SR, Khan AS, Goodman RA, et al. Retrospective diagnosis of hantavirus pulmonary syndrome, 1978-1993 - implications for emerging infectious diseases. Arch Pathol Lab Med 1996, 120:134.
224. Huggins JW, Hsiang C-M, Cosgriff TM, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 1991, 164:1119.
225. Rusnak JM, Byrne WR, Chung KN, et al. Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. Antiviral Res 2009, 81:68.
226. Sayer WJ, Entwisle GM, Uyeno BT, Bignall RC Cortisone therapy of early epidemic hemorrhagic fever: a preliminary report. Ann Intern Med 1955, 42:839.
227. Mertz GJ, Hjelle B, Crowley M, et al. Diagnosis and treatment of New World hantavirus infections. Curr Opin Infect Dis 2006, 19:437.
228. Dietl CA, Wernly JA, Pett SB, et al. Extracorporeal membrane oxygenation support improves survival of patients with severe hantavirus cardiopulmonary syndrome. J Thorac Cardiovasc Surg 2008, 135:579.
229. Rosenberg RB, Waagner DC, Romano MJ, et al. Hantavirus pulmonary syndrome treated with inhaled nitric oxide. Pediatr Infect Dis J 1998, 17:749.
230. Adhikari N, Granton JT Inhaled nitric oxide for acute lung injury: no place for NO?. JAMA 2004, 291:629.
231. Mertz GJ, Miedzinski L, Goade D, et al. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis 2004, 39:1307.
232. Hantavirus pulmonary syndrome - United States: update recommendations for risk reduction. MMWR Morb Mortal Wkly Rep 2002, 51:1. Anonymous.
233. Klingstrom J, Plyusnin A, Vaheri A, Lundkvist A Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques. J Virol 2002, 76:444.
234. Sironen T, Klingstrom J, Vaheri A, et al. Pathology of Puumala hantavirus infection in macaques. PLoS ONE 2008, 3:e3035.
235. Choi Y, Ahn C, Seong K, et al. Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells. Vaccine 2003, 21:1867.
236. Dong GM, Han L, An Q, et al. Immunization effect of purified bivalent vaccine to haemorrhagic fever with renal syndrome manufactured from primary cultured hamster kidney cells. Chin Med J (Engl) 2005, 118:766.
237. Lu Q-Y, Zhu Z-Y, Weng J-Q Immune responses to inactivated vaccine in people naturally infected with hantaviruses. J Med Virol 1996, 49:333.
238. Song G, Huang YC, Hang CS, et al. Preliminary human trial of inactivated golden hamster kidney cell (GHKC) vaccine against haemorrhagic fever with renal syndrome (HFRS). Vaccine 1992, 10:214.
239. Yamanishi K, Tanishita O, Tamura M, et al. Development of inactivated vaccine against virus causing haemorrhagic fever with renal syndrome. Vaccine 1988, 6:278.
240. Cho HW, Howard CR, Lee HW Review of an inactivated vaccine against hantaviruses. Intervirology 2002, 45:328.
241. Park K, Kim CS, Moon KT Protective effectiveness of hantavirus vaccine. Emerg Infect Dis 2004, 10:2218.
242. Sohn YM, Rho HO, Park MS, et al. Primary humoral immune responses to formalin-inactivated hemorrhagic fever with renal syndrome vaccine (Hantavax(R)): consideration of active immunization in South Korea. Yonsei Med J 2001, 42:278.
243. Schmaljohn CS, Hasty SE, Dalrymple JM Preparation of candidate vaccinia-vectored vaccines for haemorrhagic fever with renal syndrome. Vaccine 1992, 10:10.
244. Maes P, Clement J, Van Ranst M Recent approaches in hantavirus vaccine development. Expert Rev Vaccines 2009, 8:67.
245. Hooper JH, Li D Vaccines against hantaviruses. Curr Top Microbiol Immunol 2001, 256:171.